NantWorks, Providence Health & Services Corp. genomics news
NantWorks’ NantHealth subsidiary partnered with healthcare system Providence to form a clinical genomic network for whole genomic sequencing to deliver more targeted treatment for cancer patients. The partners installed the HiSeq X Ten Sequencing System from Illumina Inc. (NASDAQ:ILMN, San Diego, Calif.) at Providence, which the partners say will establish a CLIA-approved clinical facility. NantHealth said Providence will use its clinical operating system, which can integrate genetic data from a tumor sample in 47 seconds and transfer the data in 18 seconds when combined with an integrated genomic transcriptomics analysis supercomputer.
The partners said HiSeq X Ten is the world’s first platform to deliver population-scale whole genome sequencing. In January, Illumina launched the next-generation sequencing system, which the company said can sequence whole human genomes for less than $1,000 each (see BioCentury, Jan. 20). ...